Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Pcn387 - Comparison of Eq-5d-5l and 15d Instruments in Assessing Health-Related Quality of Life in Breast Cancer Patients

Value in Health

English

PHP47 Impact of Economic and Policy Factors on China'S Health Care Expenditure

English

Php325 - Orphan Drugs‘ Market Access Challenges in Europe From a German Perspective

English

Adaptive Developmental Delay in Chagas Disease Vectors: An Evolutionary Ecology Approach

PLoS Neglected Tropical Diseases

English

Psy95 - Exploring the Potential Cost-Effectiveness of Emicizumab for Hemophilia a With Inhibitor in Italy

English

Pdb103 - Financial Access to Health Care Use in Diabetics With High-Deductible Health Plan (Hdhp)

English

Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

English

2.5 Years of Amnog in Germany – An Analysis of Benefit Assessment and Net Price Negotiation Trends

English

Pnd40 - Cost of Healthcare Resource Use by Patients With Multiple Sclerosis in France According to Disease Severity

English

Prm80 - The Use of External Data to Better Inform Survival Extrapolations in Submissions to the National Institute for Health and Care Excellence (Nice)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Public Health

Pcn387 - Comparison of Eq-5d-5l and 15d Instruments in Assessing Health-Related Quality of Life in Breast Cancer Patients

PHP47 Impact of Economic and Policy Factors on China'S Health Care Expenditure

Php325 - Orphan Drugs‘ Market Access Challenges in Europe From a German Perspective

Adaptive Developmental Delay in Chagas Disease Vectors: An Evolutionary Ecology Approach

Psy95 - Exploring the Potential Cost-Effectiveness of Emicizumab for Hemophilia a With Inhibitor in Italy

Pdb103 - Financial Access to Health Care Use in Diabetics With High-Deductible Health Plan (Hdhp)

Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

2.5 Years of Amnog in Germany – An Analysis of Benefit Assessment and Net Price Negotiation Trends

Pnd40 - Cost of Healthcare Resource Use by Patients With Multiple Sclerosis in France According to Disease Severity

Prm80 - The Use of External Data to Better Inform Survival Extrapolations in Submissions to the National Institute for Health and Care Excellence (Nice)